Robert I. Scheinman

机构：University of Colorado Anschutz Medical Campus, University of Montana · ORCID：0000-0001-8485-6620

发表论文 82 篇 · 总被引 6113 次 · h-index 30

代表论文

• Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles (2018 · Nature Nanotechnology · 被引 303)
• Complement opsonization of nanoparticles: Differences between humans and preclinical species (2021 · Journal of Controlled Release · 被引 66)
• Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins (2023 · Nature Nanotechnology · 被引 45)
• Feraheme (Ferumoxytol) Is Recognized by Proinflammatory and Anti-inflammatory Macrophages via Scavenger Receptor Type AI/II (2019 · Molecular Pharmaceutics · 被引 33)
• Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55 (2019 · Journal of Controlled Release · 被引 28)
• Nanoparticle-Binding Immunoglobulins Predict Variable Complement Responses in Healthy and Diseased Cohorts (2024 · ACS Nano · 被引 25)